298
Views
20
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

National surveillance of antimicrobial resistance among Gram-positive bacteria in Saudi Arabia

, , , , , & show all
 

Abstract

Background: Antimicrobial-resistant Gram-positive bacteria are important causes of serious infections.

Methods: Between January and December 2009, we examined clinical Gram-positive isolates from 24 hospitals across Saudi Arabia.

Results: Among the 13750 isolates, Staphylococcus aureus (62·3%) was the commonest, followed by non-group A beta-haemolytic streptococci (14·8%), group A beta-haemolytic streptococci (7·1%), coagulase-negative staphylococci (6·6%), pneumococci (6·0%), and enterococci (3·1%). Resistance rates were high among S. aureus (methicillin-resistant S. aureus: 32%), coagulase-negative staphylococci (oxacillin: 63%) and pneumococci (penicillin G: 33%; erythromycin: 26%; ceftriaxone: 11%); low among enterococci (vancomycin: 1%) and among beta-haemolytic streptococci. Resistance rates varied between regions, but comparison was complicated by differences in antibiotics tested. Many relevant antibiotics were tested against few isolates (e.g. ampicillin, vancomycin, and high-level gentamicin versus enterococci) while unhelpful tests were widely performed (e.g. cefotaxime, ceftriaxone, and imipenem versus staphylococci.

Conclusion: Resistance is widespread in staphylococci and pneumococci, but not enterococci and beta-haemolytic streptococci in Saudi Arabia. Rationalization of antibiotic panels tested is urgently needed.

This project was funded by a grant from King Abdulaziz City for Science and Technology (grant no. KACST AR-18-058). We wish to thank the Ministry of Health, Saudi Arabia for allowing us to conduct this study. We also acknowledge with thanks, the cooperation of all participating hospitals.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.